GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qyuns Therapeutics Co Ltd (HKSE:02509) » Definitions » Insider Ownership

Qyuns Therapeutics Co (HKSE:02509) Insider Ownership : 0.00 % (As of Dec. 13, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Qyuns Therapeutics Co Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Qyuns Therapeutics Co's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Qyuns Therapeutics Co's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Qyuns Therapeutics Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Qyuns Therapeutics Co Insider Ownership Historical Data

The historical data trend for Qyuns Therapeutics Co's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qyuns Therapeutics Co Insider Ownership Chart

Qyuns Therapeutics Co Annual Data
Trend Dec21 Dec22 Dec23
Insider Ownership
- - -

Qyuns Therapeutics Co Quarterly Data
Dec21 Sep22 Dec22 Jun23 Sep23 Dec23 Jun24
Insider Ownership Get a 7-Day Free Trial - - - - -

Qyuns Therapeutics Co Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Qyuns Therapeutics Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 907 Yaocheng Avenue, Room 1310, Building 1, Taizhou, Jiangsu, CHN
Qyuns Therapeutics Co Ltd is a a clinical-stage biotech company focused on biologic therapies for autoimmune and allergic diseases, with a self-developed drug pipeline.
Executives
Zhu Jing
Taizhou Xinfu Tongxin Enterprise Management Partnership (limited Partnership)
Tai Zhou Yi Yao Gao Xin Ji Shu Chan Ye Tou Zi Fa Zhan You Xian Gong Si 2201 Interest of corporation controlled by you
Tai Zhou Yi Yao Gao Xin Qu Hua Yin Jin Rong Tou Zi You Xian Gong Si 2201 Interest of corporation controlled by you
Qing Dao Xin Chen Ke Chuang Shi Ye You Xian Gong Si
Zi Jin Xin Tuo You Xian Ze Ren Gong Si
Tai Zhou Hua Cheng Yi Xue Tou Zi Ji Tuan You Xian Gong Si
Nan Jing Zi Jin Tou Zi Ji Tuan You Xian Ze Ren Gong Si
Nan Jing Shi Guo You Zi Chan Tou Zi Guan Li Kong Gu Ji Tuan You Xian Ze Ren Gong Si
Bei Jing Hong Tai Tong Chuang Tou Zi Guan Li You Xian Gong Si
Sheng Xi Tai
Tai Zhou Yi Yao Cheng Kong Gu Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Hu Kaijun 2201 Interest of corporation controlled by you
Yu Guo'an
Hangzhou Quanyi Investment Management Partnership (general Partnership)

Qyuns Therapeutics Co Headlines

No Headlines